The use of abciximab during percutaneous coronary angioplasty reduces ischaemic events, but the cost is prohibitive.
| Autor: | Mayosi BM, Latouf SE, Commerford PJ |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde [S Afr Med J] 1998 Feb; Vol. 88 (2), pp. 130-1. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|